Optical	optical	O	O
coherence	coherence	O	O
tomography	tomography	O	O
can	can	O	O
measure	measure	O	O
axonal	axonal	O	O
loss	loss	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
ethambutol-induced	ethambutol-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
.	.	O	O

PURPOSE	purpose	O	O
:	:	O	O
To	to	O	O
map	map	O	O
and	and	O	O
identify	identify	O	O
the	the	O	O
pattern	pattern	O	O
,	,	O	O
in	in	O	O
vivo	vivo	O	O
,	,	O	O
of	of	O	O
axonal	axonal	O	O
degeneration	degeneration	O	O
in	in	O	O
ethambutol-induced	ethambutol-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
using	using	O	O
optical	optical	O	O
coherence	coherence	O	O
tomography	tomography	O	O
(	(	O	O
OCT	oct	O	O
)	)	O	O
.	.	O	O

Ethambutol	ethambutol	S_chemicals	O
is	is	O	O
an	an	O	O
antimycobacterial	antimycobacterial	B_chemicals	O
agent	agent	I_chemicals	O
often	often	O	O
used	used	O	O
to	to	O	O
treat	treat	O	O
tuberculosis	tuberculosis	O	S_disease
.	.	O	O

A	a	O	O
serious	serious	O	O
complication	complication	O	O
of	of	O	O
ethambutol	ethambutol	S_chemicals	O
is	is	O	O
an	an	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
that	that	O	O
impairs	impairs	O	O
visual	visual	O	O
acuity	acuity	O	O
,	,	O	O
contrast	contrast	O	O
sensitivity	sensitivity	O	O
,	,	O	O
and	and	O	O
color	color	O	B_disease
vision	vision	O	I_disease
.	.	O	O

However	however	O	O
,	,	O	O
early	early	O	O
on	on	O	O
,	,	O	O
when	when	O	O
the	the	O	O
toxic	toxic	O	B_disease
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
is	is	O	O
mild	mild	O	O
and	and	O	O
partly	partly	O	O
reversible	reversible	O	O
,	,	O	O
the	the	O	O
funduscopic	funduscopic	O	O
findings	findings	O	O
are	are	O	O
often	often	O	O
subtle	subtle	O	O
and	and	O	O
easy	easy	O	O
to	to	O	O
miss	miss	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
Three	three	O	O
subjects	subjects	O	O
with	with	O	O
a	a	O	O
history	history	O	O
of	of	O	O
ethambutol	ethambutol	S_chemicals	O
(EMB)-induced	(emb)-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
of	of	O	O
short-	short-	O	O
,	,	O	O
intermediate-	intermediate-	O	O
,	,	O	O
and	and	O	O
long-term	long-term	O	O
visual	visual	O	O
deficits	deficits	O	O
were	were	O	O
administered	administered	O	O
a	a	O	O
full	full	O	O
neuro-ophthalmologic	neuro-ophthalmologic	O	O
examination	examination	O	O
including	including	O	O
visual	visual	O	O
acuity	acuity	O	O
,	,	O	O
color	color	O	B_disease
vision	vision	O	I_disease
,	,	O	O
contrast	contrast	O	O
sensitivity	sensitivity	O	O
,	,	O	O
and	and	O	O
fundus	fundus	O	O
examination	examination	O	O
.	.	O	O

In	in	O	O
addition	addition	O	O
,	,	O	O
OCT	oct	O	O
(	(	O	O
OCT	oct	O	O
3000	3000	O	O
,	,	O	O
Humphrey-Zeiss	humphrey-zeiss	O	O
,	,	O	O
Dublin	dublin	O	O
,	,	O	O
CA	ca	O	O
)	)	O	O
was	was	O	O
performed	performed	O	O
on	on	O	O
both	both	O	O
eyes	eyes	O	O
of	of	O	O
each	each	O	O
subject	subject	O	O
using	using	O	O
the	the	O	O
retinal	retinal	S_chemicals	O
nerve	nerve	O	O
fiber	fiber	O	O
layer	layer	O	O
(	(	O	O
RNFL	rnfl	O	O
)	)	O	O
analysis	analysis	O	O
protocol	protocol	O	O
.	.	O	O

OCT	oct	O	O
interpolates	interpolates	O	O
data	data	O	O
from	from	O	O
100	100	O	O
points	points	O	O
around	around	O	O
the	the	O	O
optic	optic	O	B_disease
nerve	nerve	O	I_disease
to	to	O	O
effectively	effectively	O	O
map	map	O	O
out	out	O	O
the	the	O	O
RNFL	rnfl	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
The	the	O	O
results	results	O	O
were	were	O	O
compared	compared	O	O
to	to	O	O
the	the	O	O
calculated	calculated	O	O
average	average	O	O
RNFL	rnfl	O	O
of	of	O	O
normal	normal	O	O
eyes	eyes	O	O
accumulated	accumulated	O	O
from	from	O	O
four	four	O	O
prior	prior	O	O
studies	studies	O	O
using	using	O	O
OCT	oct	O	O
,	,	O	O
n=661	n=661	O	O
.	.	O	O

In	in	O	O
all	all	O	O
subjects	subjects	O	O
with	with	O	O
history	history	O	O
of	of	O	O
EMB-induced	emb-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
,	,	O	O
there	there	O	O
was	was	O	O
a	a	O	O
mean	mean	O	O
loss	loss	O	B_disease
of	of	O	I_disease
72	72	O	O
%	%	O	O
nerve	nerve	O	O
fiber	fiber	O	O
layer	layer	O	O
thickness	thickness	O	O
in	in	O	O
the	the	O	O
temporal	temporal	O	O
quadrant	quadrant	O	O
(	(	O	O
patient	patient	O	O
A	a	O	O
,	,	O	O
with	with	O	O
eventual	eventual	O	O
recovery	recovery	O	O
of	of	O	O
visual	visual	O	O
acuity	acuity	O	O
and	and	O	O
fields	fields	O	O
,	,	O	O
58	58	O	O
%	%	O	O
loss	loss	O	O
;	;	O	O
patient	patient	O	O
B	b	O	O
,	,	O	O
with	with	O	O
intermediate	intermediate	O	O
visual	visual	O	O
deficits	deficits	O	O
,	,	O	O
68	68	O	O
%	%	O	O
loss	loss	O	O
;	;	O	O
patient	patient	O	O
C	c	O	O
,	,	O	O
with	with	O	O
chronic	chronic	O	O
visual	visual	O	O
deficits	deficits	O	O
,	,	O	O
90	90	O	O
%	%	O	O
loss	loss	O	O
)	)	O	O
,	,	O	O
with	with	O	O
an	an	O	O
average	average	O	O
mean	mean	O	O
optic	optic	O	B_disease
nerve	nerve	O	I_disease
thickness	thickness	O	O
of	of	O	O
26+/-16	26+/-16	O	O
microm	microm	O	O
.	.	O	O

There	there	O	O
was	was	O	O
a	a	O	O
combined	combined	O	O
mean	mean	O	O
loss	loss	O	B_disease
of	of	O	I_disease
46	46	O	O
%	%	O	O
of	of	O	O
fibers	fibers	O	O
from	from	O	O
the	the	O	O
superior	superior	O	O
,	,	O	O
inferior	inferior	O	O
,	,	O	O
and	and	O	O
nasal	nasal	O	O
quadrants	quadrants	O	O
in	in	O	O
the	the	O	O
(	(	O	O
six	six	O	O
)	)	O	O
eyes	eyes	O	O
of	of	O	O
all	all	O	O
three	three	O	O
subjects	subjects	O	O
(	(	O	O
mean	mean	O	O
average	average	O	O
thickness	thickness	O	O
of	of	O	O
55+/-29	55+/-29	O	O
microm	microm	O	O
)	)	O	O
.	.	O	O

In	in	O	O
both	both	O	O
sets	sets	O	O
(	(	O	O
four	four	O	O
)	)	O	O
of	of	O	O
eyes	eyes	O	O
of	of	O	O
the	the	O	O
subjects	subjects	O	O
with	with	O	O
persistent	persistent	O	O
visual	visual	O	O
deficits	deficits	O	O
(	(	O	O
patients	patients	O	O
B	b	O	O
and	and	O	O
C	c	O	O
)	)	O	O
,	,	O	O
there	there	O	O
was	was	O	O
an	an	O	O
average	average	O	O
loss	loss	O	B_disease
of	of	O	I_disease
79	79	O	O
%	%	O	O
of	of	O	O
nerve	nerve	O	O
fiber	fiber	O	O
thickness	thickness	O	O
in	in	O	O
the	the	O	O
temporal	temporal	O	O
quadrant	quadrant	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
The	the	O	O
OCT	oct	O	O
results	results	O	O
in	in	O	O
these	these	O	O
patients	patients	O	O
with	with	O	O
EMB-induced	emb-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
show	show	O	O
considerable	considerable	O	O
loss	loss	O	O
especially	especially	O	O
of	of	O	O
the	the	O	O
temporal	temporal	O	O
fibers	fibers	O	O
.	.	O	O

This	this	O	O
is	is	O	O
consistent	consistent	O	O
with	with	O	O
prior	prior	O	O
histopathological	histopathological	O	O
studies	studies	O	O
that	that	O	O
show	show	O	O
predominant	predominant	O	O
loss	loss	O	B_disease
of	of	O	I_disease
parvo-cellular	parvo-cellular	O	O
axons	axons	O	O
(	(	O	O
or	or	O	O
small-caliber	small-caliber	O	O
axons	axons	O	O
)	)	O	O
within	within	O	O
the	the	O	O
papillo-macular	papillo-macular	O	O
bundle	bundle	O	O
in	in	O	O
toxic	toxic	O	O
or	or	O	O
hereditary	hereditary	O	B_disease
optic	optic	O	B_disease
neuropathies	neuropathies	O	I_disease
.	.	O	O

OCT	oct	O	O
can	can	O	O
be	be	O	O
a	a	O	O
valuable	valuable	O	O
tool	tool	O	O
in	in	O	O
the	the	O	O
quantitative	quantitative	O	O
analysis	analysis	O	O
of	of	O	O
optic	optic	O	B_disease
neuropathies	neuropathies	O	I_disease
.	.	O	O

Additionally	additionally	O	O
,	,	O	O
in	in	O	O
terms	terms	O	O
of	of	O	O
management	management	O	O
of	of	O	O
EMB-induced	emb-induced	O	O
optic	optic	O	B_disease
neuropathy	neuropathy	O	I_disease
,	,	O	O
it	it	O	O
is	is	O	O
important	important	O	O
to	to	O	O
properly	properly	O	O
manage	manage	O	O
ethambutol	ethambutol	S_chemicals	O
dosing	dosing	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
renal	renal	O	O
impairment	impairment	O	O
and	and	O	O
to	to	O	O
achieve	achieve	O	O
proper	proper	O	O
transition	transition	O	O
to	to	O	O
a	a	O	O
maintenance	maintenance	O	O
dose	dose	O	O
once	once	O	O
an	an	O	O
appropriate	appropriate	O	O
loading	loading	O	O
dose	dose	O	O
has	has	O	O
been	been	O	O
reached	reached	O	O
.	.	O	O

